Effect of progression-free interval (PFI) following penultimate platinum-based regimen on the efficacy of rucaparib maintenance treatment in patients with platinum-sensitive, recurrent ovarian carcinoma: An analysis from the phase 3 study ARIEL3 Meeting Abstract
| Authors: | Clamp, A. R.; Oza, A. M.; Lorusso, D.; Aghajanian, C.; Oaknin, A.; Dean, A.; Colombo, N.; Weberpals, J. I.; Scambia, G.; Leary, A.; Holloway, R. W.; Amenedo Gancedo, M.; Fong, P. C.; Goh, I. C.; O'Malley, D. M.; Armstrong, D. K.; Banerjee, S.; Garcia-Donas, J.; Swisher, E. M.; Cameron, T.; Maloney, L.; Goble, S.; Coleman, R. L.; Ledermann, J. A. |
| Abstract Title: | Effect of progression-free interval (PFI) following penultimate platinum-based regimen on the efficacy of rucaparib maintenance treatment in patients with platinum-sensitive, recurrent ovarian carcinoma: An analysis from the phase 3 study ARIEL3 |
| Meeting Title: | 21st International Meeting of the European Society of Gynaecological Oncology (ESGO) |
| Journal Title: | International Journal of Gynecological Cancer |
| Volume: | 29 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2019 Nov 2-5 |
| Meeting Location: | Athens, Greece |
| ISSN: | 1048-891X |
| Publisher: | Lippincott Williams & Wilkins |
| Date Published: | 2019-11-01 |
| Start Page: | A27 |
| End Page: | A28 |
| Language: | English |
| ACCESSION: | WOS:000523502500029 |
| DOI: | 10.1136/ijgc-2019-ESGO.28 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
